Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and other areas; and injectables in the areas of IDA, MRI agents, oncology, and others. It also provides contract development and manufacturing services, including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization; injectable manufacturing and secondary packaging, labeling, and serialization services; custom fermentation services; and peptide synthesis services. In addition, the company offers antibody-drug conjugates services comprising antibody development and manufacture; peptide and polymer drug conjugation; Linker-payload design, synthesis, and manufacturing; bio-conjugation and purification; cytotoxic liquid-filled and lyophilized product from pre-formulation studies to manufacture; and regulatory support. Further, it is involved in chemical trading and investment activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan, Taiwan.

Formosa Laboratories Inc

Dr. Chen-Yu  Cheng Ph.D.

President & Chairman of the Board

Ms. S. J. Liou B.S.

Senior Vice President of Business

Ms. Michelle  Lo

Senior Vice President of Corporate Support Division

Mr. Hengui  Huang

Senior Vice President of Quality & Regulatory Compliance Division

Mr. Hank  Chen

Senior Vice President of Production

Xian-Gui  Huang

Vice President

Ling-Fang  Yang

Chien-Fei  Lin

Chief Information Security Officer

4746's next earnings is on June 25, 2025 (After Market Close)

4746's latest dividend is 2 TWD on July 27, 2022

Formosa Laboratories Inc (4746) Stock Analysis, Discussion Forum and Financial Metrics - TWSE Exchange

Formosa Laboratories Inc (4746) Earnings Report Date and History | TWSE

4746's next earnings is on June 25, 2025 (After Market Close)

When is the earnings report for 4746?

4746 Earnings History

4746's latest dividend is 2 TWD on July 27, 2022

4746 Stock Discussion Forum and Message Board

News for TWSE: 4746